Skip to main content
DOCS
NYSE Technology

Doximity Q1 profit halves as AI spending surges; $91.6M buyback executed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$21.77
Mkt Cap
$3.714B
52W Low
$17.15
52W High
$76.51
52W Position info
27% above low
Off High info
72% below high
Rel. Volume info
3.8× avg
Market data snapshot near publication time

DOCS sits 27% above its 52-week low of $17.15 on elevated volume (3.8× avg).

Summary

Doximity's Q1 FY2027 net income fell 54% to $24.3M as AI spending surged, but revenue grew 7% to $156.6M. The company bought back $91.6M in stock and settled its securities lawsuit.


Key Events · Earnings and Guidance · DOCS

  • Net Income Halves on AI Spend

    Net income fell 54% YoY to $24.3M as operating expenses jumped 31% to $99.3M, driven by a $11.7M increase in R&D and $8.7M in sales and marketing, largely tied to AI initiatives.

  • Revenue Up 7%, Margins Compress

    Revenue reached $156.6M, up 7% YoY, but gross margin declined to 85% from 89% due to higher hosting and software costs for AI. Adjusted EBITDA margin fell to 48% from 55%.

  • $91.6M Buyback Executed

    Doximity repurchased 4.4M shares for $91.6M under its $500M program, with $400.9M remaining. The prior $500M program was completed in FY2026.

  • Securities Lawsuit Settled

    The $31M class action settlement received final court approval in June 2026, removing a major legal overhang. Derivative lawsuits remain pending.


Analysis · DOCS · Technology

Net income fell 54% year-over-year to $24.3 million despite a 7% revenue gain, as heavy AI investment pushed operating expenses up 31%. Gross margin compressed four points to 85%. The company deployed $91.6 million on buybacks, leaving $400.9 million under its current authorization. A major legal overhang was removed when the securities class action settled for $31 million, while the OpenEvidence case is now in mediation. The new CFO officially took over in June. The quarter shows a profitable platform absorbing significant AI investment, but margin compression and an elevated tax rate are headwinds to watch.

At the time of this filing, DOCS was trading at $21.77 on NYSE in the Technology sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $17.15 to $76.51. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DOCS - Latest Insights

DOCS
May 19, 2026, 4:08 PM EDT
Filing Type: 10-K
Importance Score:
7
DOCS
May 14, 2026, 3:54 AM EDT
Source: Wiseek News
Importance Score:
7
DOCS
May 13, 2026, 4:36 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
DOCS
May 13, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
DOCS
May 13, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7